LTEN 2026: The Conference That Pressure-Tests What's Working
There are plenty of places to hear new ideas about training. What's harder to find is a place where those ideas get tested against how teams are actually operating. That's...
Read More →
There are plenty of places to hear new ideas about training. What's harder to find is a place where those ideas get tested against how teams are actually operating. That's...
Read More →
Margie Gozdiff has spent more than three decades helping leaders get better at the thing most of them were never formally taught: developing other people. The pattern she sees everywhere,...
Read More →
In pharmaceutical field teams, tenure is often treated as an advantage. In practice, it can slow development. Representatives know their physicians. They know the science. They know their territory, sometimes...
Read More →
Before there was a company, there was a rep. She was Ed's best. Hitting every number, exceeding every target, the kind of salesperson a manager thanks their lucky stars for...
Read More →
When did you last design a coaching plan specifically for a rep who was neither struggling nor excelling? Take a moment with that. Not a field ride. Not a debrief...
Read More →
Do you know the difference between a rep who can't and a rep who won't? It sounds like a simple question. Most sales leaders will tell you they do. But...
Read More →
There’s a moment in leadership development when everything clicks. When a leader moves from executing the mechanics of coaching to intentionally shaping how they show up for their team. This...
Read More →
Put yourself in the shoes of a first-line manager… You've been managing Sarah for five years. You know her kids' names, her territory challenges, her preferred working style. Your field...
Read More →
For most pharmaceutical commercial teams, coaching is embedded in the operating model. First-line managers coach. Field visits happen. Coaching reports are completed. What is far less common is certainty. Certainty...
Read More →
Your sales team is under pressure. Regulatory norms are shifting. Tariffs are reshaping supply chains. Government–pharma partnerships are changing how decisions get made. At the same time, reps are navigating...
Read More →